Rehab Cognitive denied as duplicate or overlapping therapy by UnitedHealthcare?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What UnitedHealthcare typically requires
UnitedHealthcare's specific coverage criteria for rehab cognitive are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The UnitedHealthcare angle on Rehab Cognitive
## Why UnitedHealthcare Denied Your Cognitive Rehabilitation as Duplicate Therapy
UnitedHealthcare issues a duplicate-therapy denial for cognitive rehabilitation when its reviewers determine that another service being provided — such as general speech-language pathology, occupational therapy, neuropsychological sessions, or another structured rehabilitation program — is already addressing the same cognitive deficits. The logic is that paying for two services targeting identical functional goals is not medically necessary. These denials are frequently overturned on appeal because cognitive rehabilitation programs are highly structured, protocol-driven interventions that address specific cognitive domains (attention, memory, executive function, processing speed) in ways that differ materially from general supportive therapy or unstructured clinical visits.
## Your Right to Appeal
- Internal appeal: File a written appeal with UHC within the deadline on your denial letter (commonly 180 days for most plans). Request the specific medical policy and clinical criteria applied to the duplicate-therapy determination.
- External review (ACA §2719): After exhausting the internal process, you may request IRO external review — generally within four months of your final internal denial. A neurologist, neuropsychologist, or rehabilitation medicine specialist may serve as the independent reviewer.
- Expedited review: Available if your condition is urgent, with a decision typically required within 72 hours.
- ERISA §503: Employer-sponsored plan members retain full-and-fair review rights and federal court access after exhaustion.
## Documentation to Gather
1. Program description and treatment plan: A detailed document from the cognitive rehabilitation provider describing the specific protocols, targeted cognitive domains, session structure, and measurable goals — this is critical for distinguishing the program from general therapy. 2. Differentiation from concurrent services: A letter from each treating provider explaining what their service addresses and how cognitive rehabilitation addresses something distinct — not overlapping goals with different branding, but genuinely different functional targets. 3. Diagnosis and neuropsychological assessment: A current neuropsychological evaluation or cognitive assessment documenting the specific deficits being treated, their origin (acquired brain injury, stroke, neurocognitive disorder, etc.), and their functional impact. 4. Prescriber or specialist medical-necessity letter: A letter from the referring or supervising clinician — ideally a neurologist, neuropsychologist, or physiatrist — explaining the clinical basis for concurrent services and citing the applicable guideline organization (such as relevant brain injury rehabilitation or cognitive neuroscience guidelines).
## Criteria-Mapping Strategy
Obtain UHC's published medical policy for cognitive rehabilitation and the specific policy language used to define "duplicate therapy." List every criterion. For each criterion, document in writing how the cognitive rehabilitation program is distinct — different provider, different protocol, different cognitive domain targets, different measurable outcomes. Reviewers and IRO clinicians respond well to a structured exhibit that maps each duplicate-therapy criterion to a specific, documented clinical distinction.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- UnitedHealthcare denied as duplicate or overlapping therapy of ABA Autism
- UnitedHealthcare denied as duplicate or overlapping therapy of Amphetamine Stimulant
- UnitedHealthcare denied as duplicate or overlapping therapy of Amphetamine Stimulant Prodrug
- UnitedHealthcare denied as duplicate or overlapping therapy of Anti Amyloid Leqembi